You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

GLP-1 receptor agonist (liraglutide)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Healthy Trial in Singapore (LY3537021, Liraglutide, Placebo)

Active, not recruiting
  • Healthy
  • Singapore, Singapore
    Lilly Centre for Clinical Pharmacology
Nov 22, 2022

Type 2 Diabetes, Peripheral Arterial Disease Trial in Napoli (Liraglutide, Control)

Recruiting
  • Type 2 Diabetes
  • Peripheral Arterial Disease
  • Napoli, Italy
    Unit of Endocrinology and Metabolic Diseases and Unit of Diabete
Jun 9, 2021

Type 1 Diabetes Trial in Uppsala (Liraglutide, Placebo for liraglutide)

Completed
  • Type 1 Diabetes
  • Uppsala, Sweden
    Uppsala University Hospital
Nov 4, 2020

Incidence of Retained Gastric Food on Endoscopy

Not yet recruiting
  • Gastric Content Aspiration
  • Esophagogastroduodenoscopy
  • (no location specified)
May 16, 2023

Glucagon-like Peptide-1 Receptor Agonists According to Type 2

Recruiting
  • Diabetes Mellitus, Type 2
  • GLP-1 receptor agonist
  • Bari, Italy
    Azienda Ospedaliero-Universitaria Policlinico Bari
Nov 4, 2023

Obesity Trial in Ras al-Khaimah (POSE2.0 Endoscopic Gastric Remodeling, Liraglutide injection)

Recruiting
  • Obesity
  • POSE2.0 Endoscopic Gastric Remodeling
  • Liraglutide injection
  • Ras al-Khaimah, United Arab Emirates
    Ibrahim Bin Hamad Obaidullah Hospital
Jan 27, 2023

Caveolin 1 Deficiency in Response to Glucagon-like Peptide 1

Not yet recruiting
  • Overweight and Obesity
  • 24-hour ambulatory blood pressure
  • Liberal salt diet
  • (no location specified)
Oct 4, 2023

Morbid Obesity, Metabolic Syndrome, Diabetes Trial in Columbia (GLP-1 receptor agonist)

Not yet recruiting
  • Morbid Obesity
  • +4 more
  • GLP-1 receptor agonist
  • Columbia, Missouri
    University of Missouri Hospital
Nov 20, 2023

Glucagon-like Peptide 1 Receptor Agonists and Mental Health

Not yet recruiting
  • Diabetes Mellitus
  • +2 more
  • GLP-1 receptor agonist
  • (no location specified)
Aug 4, 2022

Obesity Trial in Mansourah, Mansoura (Liraglutide)

Recruiting
  • Obesity
  • Mansourah, Dakhlia, Egypt
  • +1 more
Feb 24, 2022

Pulmonary Disease, Chronic Obstructive Trial in Esbjerg, Vejle (Liraglutide, Placebo)

Completed
  • Pulmonary Disease, Chronic Obstructive
  • Esbjerg, Denmark
  • +1 more
Mar 12, 2021

Type 2 Diabetes Trial in Xuzhou (GLP-1 receptor agonist)

Recruiting
  • Type 2 Diabetes Mellitus
  • GLP-1 receptor agonist
  • Xuzhou, Jiangsu, China
    Department of Endocrinology
Apr 16, 2022

Osteoporosis, Postmenopausal, Diabetes, Type 2 Trial in Jackson (GLP-1 receptor agonist)

Recruiting
  • Osteoporosis, Postmenopausal
  • Diabetes Mellitus, Type 2
  • GLP-1 receptor agonist
  • Jackson, Mississippi
    University of Mississippi Medical Center
Aug 5, 2022

SEMAGLUTIDE VERSUS GLP-1 RECEPTOR AGONISTS. EFFECTIVENESS ,

Active, not recruiting
  • Weight Loss
  • +3 more
  • GLP-1 receptor agonist
  • Culleredo, A Coruña, Spain
  • +10 more
Jan 13, 2023

Type 2 Diabetes, Comparative Effectiveness of Glycemia-lowering Medications Trial in United States (Sulfonylurea (glimepiride),

Completed
  • Type 2 Diabetes
  • Comparative Effectiveness of Glycemia-lowering Medications
  • Sulfonylurea (glimepiride)
  • +3 more
  • Birmingham, Alabama
  • +35 more
Apr 13, 2022

Type2Diabetes, ASCVD Trial (SGLT2 inhibitor, GLP-1 receptor agonist, Combination drug)

Recruiting
  • Type2Diabetes
  • ASCVD
  • SGLT2 inhibitor
  • +2 more
  • New York, New York
  • +1 more
Dec 19, 2022

Alcohol Abuse, Alcohol Addiction, Alcohol Dependence Trial in Frederiksberg (Semaglutide Injectable Product, Placebo)

Recruiting
  • Alcohol Abuse
  • +3 more
  • Semaglutide Injectable Product
  • Placebo
  • Frederiksberg, Denmark
    Psychiatric Center Copenhagen, Frederiksberg Hospital
Jun 13, 2023

Semaglutide Use in Acute Pulmonary Embolism

Completed
  • Pulmonary Embolism
  • London, United Kingdom
    Colm McCabe
Nov 3, 2023

GLP-1 Receptor Agonists on Efficacy and Persistence, Adherence

Completed
  • Type 2 Diabetes
  • Obesity
  • Valencia, Spain
    INCLIVA
Sep 6, 2022

Ischemic Stroke Trial in Herlev (Byetta, Normosaline)

Recruiting
  • Ischemic Stroke
  • Herlev, Denmark
    Department of Neurology, Herlev-Gentofte Hospital
Nov 13, 2021

Obesity Trial in Hamburg (GLP-1 (Liraglutide), Placebo)

Terminated
  • Obesity
  • GLP-1 (Liraglutide)
  • Placebo
  • Hamburg, Germany
    University Medical Center Hamburg
Jun 29, 2022

Diabetes Trial in Nanjing (Duragtide, Semaglutide, losenatide, tirzepatide, ebenatide, etc)

Recruiting
  • Diabetes
  • Duragtide, Semaglutide, losenatide, tirzepatide, ebenatide, etc
  • Nanjing, China
    Nanjing First Hospital, Nanjing Medical Univesity
Aug 6, 2023

Obesity, Liver Diseases, Liver Fibrosis Trial in Boston (ESG, GLP1-RA)

Not yet recruiting
  • Obesity
  • +16 more
  • Boston, Massachusetts
    Brigham and Women's Hospital
Nov 14, 2023

Preoperative Prandial State of Patients Taking Glucagon-Like

Recruiting
  • Pulmonary Aspiration
  • Gastric ultrasound
  • Houston, Texas
    The University of Texas Health Science Center at Houston
Jun 6, 2023

Cystic Fibrosis, Pancreatic Insufficiency, Abnormal Glucose Tolerance Trial in Philadelphia (Dulaglutide 0.75Mg/0.5Ml Inj Pen)

Recruiting
  • Cystic Fibrosis
  • +3 more
  • Dulaglutide 0.75Mg/0.5Ml Inj Pen
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Jan 11, 2023